biOasis Technologies Inc
OTC:BIOAF
Balance Sheet
Balance Sheet Decomposition
biOasis Technologies Inc
biOasis Technologies Inc
Balance Sheet
biOasis Technologies Inc
| Feb-2013 | Feb-2014 | Feb-2015 | Feb-2016 | Feb-2017 | Feb-2018 | Feb-2019 | Feb-2020 | Feb-2021 | Feb-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
2
|
|
| Cash Equivalents |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
3
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
3
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
3
-33%
|
2
-14%
|
2
-3%
|
1
-48%
|
1
+10%
|
2
+43%
|
1
-46%
|
3
+248%
|
2
-31%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Total Liabilities |
0
N/A
|
0
-21%
|
0
+11%
|
0
+107%
|
1
+72%
|
1
+5%
|
2
+191%
|
3
+50%
|
3
-16%
|
4
+46%
|
|
| Equity | |||||||||||
| Common Stock |
13
|
15
|
17
|
18
|
19
|
23
|
24
|
25
|
27
|
27
|
|
| Retained Earnings |
14
|
17
|
20
|
23
|
26
|
31
|
34
|
38
|
38
|
41
|
|
| Additional Paid In Capital |
4
|
5
|
5
|
6
|
7
|
9
|
10
|
10
|
11
|
11
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
2
-33%
|
2
-16%
|
2
-14%
|
0
-79%
|
0
+19%
|
1
N/A
|
2
-355%
|
0
N/A
|
2
N/A
|
|
| Total Liabilities & Equity |
4
N/A
|
3
-33%
|
2
-14%
|
2
-3%
|
1
-48%
|
1
+10%
|
2
+43%
|
1
-46%
|
3
+248%
|
2
-31%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
40
|
42
|
44
|
45
|
46
|
52
|
59
|
64
|
72
|
73
|
|